{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} So Where is a Vaccine for Respiratory Syncytial Virus?
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Learning Objectives
After completing this continuing education activity you will be able to:
- Recognize the prevalence and consequences of respiratory syncytial virus.
- Choose the clinical implications of respiratory syncytial virus.
- Identify the challenges of respiratory syncytial virus vaccine development.
- Select the appropriate treatment options for patients who have respiratory syncytial virus.
Learning Outcomes
Seventy-five percent of participants will demonstrate knowledge of respiratory syncytial virus, including epidemiology, clinical manifestations, vaccine development, and current clinical care, by achieving a minimum score of 70% on the outcomes-based posttest.Disclosures
The author and planners have no relevant financial relationships with any ineligible organizations regarding this activity.
Price:
$17.95
Credits:
- ANCC 1.5 CH
- DC - BON 1.5 CH
- FL - BON 1.5 CH
- GA - BON 1.5 CH
- NM - BON 1.5 CH
- SC - BON 1.5 CH
- WV - BOERN 1.5 CH
Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: CNS0323
Published: Mar/Apr 2023
Expires: 3/7/2025
Required Passing Score: 8/10 (80%)